D. Boral Capital Cuts Reviva Pharmaceuticals (NASDAQ:RVPH) Price Target to $3.00
Reviva Pharmaceuticals (NASDAQ:RVPH – Free Report) had its price target reduced by D. Boral Capital from $8.00 to $3.00 in a research note issued to investors on Tuesday,Benzinga reports. They currently have a buy rating on the stock. Separately, HC Wainwright cut their target price on Reviva Pharmaceuticals from $14.00 to $11.00 and set a […]
Reviva Pharmaceuticals (NASDAQ:RVPH – Free Report) had its price target reduced by D. Boral Capital from $8.00 to $3.00 in a research note issued to investors on Tuesday,Benzinga reports. They currently have a buy rating on the stock. Separately, HC Wainwright cut their target price on Reviva Pharmaceuticals from $14.00 to $11.00 and set a […]
